Publication | Closed Access

ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF

Hematological MalignancyLymphoid NeoplasiaPretreated Non-hodgkinMedicineMalignant Blood DisorderImmunologyHematologyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyCancer ResearchHealth Sciences